| 1301/1507 | US=1-B / Farmacologia Baldessarini RJ. Drug therapy of depression and anxiety disorders. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 429-59. ISBN 978-0-071-142280-3. TERAPIA MEDICAMENTOSA DE DEPRESSAO; MEDICAMENTOS DE TRANSTORNOS DE ANSIEDADE; CARACTERIZACAO DE DEPRESSIVO; DISTURBIOS DE ANSIEDADE; ANTIDEPRESSIVOS; FARMACOTERAPIA DA ANSIEDADE |
| 1302/1507 | US=1-B / Farmacologia Hoffman BB. Therapy of hypertension. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 845-68. ISBN 978-0-071-142280-3. TERAPIA DA HIPERTENSAO; DIURETICOS; SIMPATOLITICOS; ANTAGONISTAS DOS CANAIS; INIBIDORES DA ENZIMA; CONVERSORA DE ANGIOTENSINA; ANTAGONISTAS DOS RECEPTORES DA ANGIOTENSINA; VASODILATADORES; TERAPIA NAO FARMACOLOGICA DA HIPERTENSAO; SELECAO DE MEDICAMENTOS ANTI-HIPERTENSIVOS; PACIENTES INDIVIDUAIS |
| 1303/1507 | US=1-B / Farmacologia Hoffman BB. Therapy of hypertension. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 845-68. ISBN 978-0-071-142280-3. TERAPIA DA HIPERTENSAO; DIURETICOS; SIMPATOLITICOS; ANTAGONISTAS DOS CANAIS; INIBIDORES DA ENZIMA; CONVERSORA DE ANGIOTENSINA; ANTAGONISTAS DOS RECEPTORES DA ANGIOTENSINA; VASODILATADORES; TERAPIA NAO FARMACOLOGICA DA HIPERTENSAO; SELECAO DE MEDICAMENTOS ANTI-HIPERTENSIVOS; PACIENTES INDIVIDUAIS; DOPAMINERGICO |
| 1304/1507 | US=1-B / Farmacologia Mahley RW, Bersot TP. Drug therapy for hypercholesterolemia and dyslipidemia. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 933-66. ISBN 978-0-071-142280-3. TERAPIA MEDICAMENTOSA PARA HIPERCOLESTEROLEMIA; TERAPIA MEDICAMENTOSA PARA DISLIPIDEMIA; METABOLISMO DE LIPOPROTEINAS PLASMATICAS; HIPERLIPIDEMIA; ATEROSCLEROSE; TRATAMENTO MEDICAMENTOSO DA DISLIPIDEMIA |
| 1305/1507 | US=2 / Biol/Mol Gülow K, Kaminski M, Krammer PH. Death receptor: the role of CD95/CD95 ligand signaling in apoptosis and cancer. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 3-30. ISBN 978-3-527-31237-5. RECEPTOR MORTE; SISTEMA CD95; SISTEMA CD95L; SINALIZACAO DA APOPTOSE; CANCER; MAQUINARIA APOPTOTICA; VIA INTRINSECA; VIA EXTRINSECA; MITOCONDRIAS; MECANISMOS DE RESISTENCIA; ANGIOGENESE |
| 1306/1507 | US=1-B / Farmacologia Chambers HF. General principles of antimicrobial therapy. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1095-1110. ISBN 978-0-071-142280-3. |
| 1307/1507 | US=2 / Biol/Mol Walczak H, Koschny R, Willen D, Schader MB, Sykora J, Ganten TM, Haas TL. Death receptor: the TRAIL receptor-ligand system: biochemistry of apoptosis induction, therapeutic potential for cancer treatment and physiological function. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 31-92. ISBN 978-3-527-31237-5. RECEPTOR MORTE; SISTEMA DE RECEPTOR-LIGANTE TRAIL; BIOQUIMICA DA INDUCAO DE APOPTOSE; POTENCIAL TERAPEUTICO; CANCER. TERAPIA; FUNCAO FISIOLOGICA; ATIVACAO DA CASPASE; FAMILIA BCL-2; UBIQUITINA; TERAPIA GENETICA; INFECCAO VIRAL; IMUNOPATOLOGIAS; DOENCAS AUTO-IMUNES; TRANSPLANTE ALOGENICO DE CELULAS-TRONCO HEMATOPOETICAS |
| 1308/1507 | US=2 / Biol/Mol Wajant H. Death receptor: mechanisms of tumor necrosis factor-induced cell death. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 93-119. ISBN 978-3-527-31237-5. RECEPTOR DE MORTE; MORTE CELULAR; FATOR DE NECROSE TUMORAL; APOPTOSE; CANCER. TERAPIA |
| 1309/1507 | US=2 / Biol/Mol Micheau O. Death receptor: cellular FLICE-inhibitory protein: an update. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 120-56. ISBN 978-3-527-31237-5. CANCER; RECEPTOR MORTE; PROTEINA INIBITORIA DA FLICE; GENE FLIP |
| 1310/1507 | US=2 / Biol/Mol Mehlen P, Lourenço FC. Death receptor: dependence receptors and apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 157-82. ISBN 978-3-527-31237-5. RECEPTOR DE MORTE; RECEPTORES DE DEPENDENCIA; APOPTOSE; INTEGRINA; TIROSINA QUINASE |
| 1311/1507 | US=2 / Biol/Mol Saelens X, Festjens N, Walle LV, Vandenabeele P. Mitochondria: role of mitochondrial proteins in apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 183-221. ISBN 978-3-527-31237-5. APOPTOSE; PAPEL DAS PROTEINAS MITOCONDRIAIS; FAMILIA BCL-2; PERMEABILIZACAO DA MEMBRANA MITOCONDRIAL; MUTACOES APOPTOTICAS; CITOCROMO C |
| 1312/1507 | US=2 / Biol/Mol Suzuki Y, Takahashi R. Mitochondria: omi/HtrA2: a mitochondrial serine protease regulating cellular life and death. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 222-32. ISBN 978-3-527-31237-5. MITOCONDRIAS; OMI/HTRA2; SERINA PROTEASE MITOCONDRIAL; MORTE CELULAR |
| 1313/1507 | US=2 / Biol/Mol Vahsen N, Kroemer G. Mitochondria: apoptosis-inducing factor. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 233-55. ISBN 978-3-527-31237-5. |
| 1314/1507 | US=2 / Biol/Mol Adrain C, Martin SJ. Effector systems: caspases: agents of defense and destruction. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 259-81. ISBN 978-3-527-31237-5. |
| 1315/1507 | US=2 / Biol/Mol Cain K. Effector systems: the role of the apoptosome and cancer therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 282-313. ISBN 978-3-527-31237-5. SISTEMAS EFETORES; TERAPIA APOPTOSSOMO; CANCER; CITOCROMO C; CASPASE |
| 1316/1507 | US=2 / Biol/Mol Naik E, Strasser A. Bcl-2 family: the role of the Bcl-2 protein family in tumorigenesis and cancer therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 317-45. ISBN 978-3-527-31237-5. FAMILIA BCL-2; TUMORIGENESE; CANCER. TERAPIA; MORTE CELULAR; APOPTOSE |
| 1317/1507 | US=2 / Biol/Mol Dempsey CE, Roberts DL, Dive C. Bcl-2 family: bax, bak and bid: key mediators of apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 346-78. ISBN 978-3-527-31237-5. FAMILIA BCL-2; BAX; BAK; BID; MEDIADORES DE APOPTOSE; VIAS MITOCONDRIAIS; CANCER |
| 1318/1507 | US=2 / Biol/Mol Erlacher M, Michalak EM, Strasser A, Villunger A. Bcl-2 family: the BH3-only proteins puma and noxa: two brothers in arms. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 379-402. ISBN 978-3-527-31237-5. FAMILIA BCL-2; PROTEINAS BH3; PUMA; NOXA; REGULACAO DA P53; MORTE CELULAR |
| 1319/1507 | US=2 / Biol/Mol Holcik M. IAPs: inhibitor of apoptosis proteins. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 403-26. ISBN 978-3-527-31237-5. |
| 1320/1507 | US=2 / Biol/Mol Altieri DC. IAPs: targeting the survivin pathway for rational cancer therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 427-42. ISBN 978-3-527-31237-5. |